REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,065,918 | -13.5% | 3,145,445 | -16.4% | 1.02% | -14.4% |
| Q2 2023 | $100,616,781 | +35.7% | 3,761,375 | +9.9% | 1.19% | +18.2% |
| Q1 2023 | $74,141,574 | +591.7% | 3,422,972 | +660.6% | 1.01% | +605.6% |
| Q4 2022 | $10,719,357 | -3.6% | 450,015 | -20.2% | 0.14% | -7.7% |
| Q3 2022 | $11,120,000 | +116.3% | 563,881 | +113.8% | 0.16% | +96.2% |
| Q2 2022 | $5,141,000 | -91.4% | 263,799 | -88.7% | 0.08% | -91.8% |
| Q1 2022 | $59,474,000 | -19.4% | 2,331,395 | -20.4% | 0.96% | -8.6% |
| Q4 2021 | $73,749,000 | +208.3% | 2,930,038 | +237.0% | 1.06% | +170.1% |
| Q3 2021 | $23,920,000 | -11.5% | 869,484 | +2.1% | 0.39% | -22.4% |
| Q2 2021 | $27,030,000 | -30.0% | 851,592 | +1.1% | 0.50% | -41.2% |
| Q1 2021 | $38,634,000 | +20.9% | 842,062 | +4.3% | 0.86% | +1.2% |
| Q4 2020 | $31,954,000 | +3190.8% | 807,130 | +2791.8% | 0.85% | +2546.9% |
| Q3 2020 | $971,000 | -19.2% | 27,911 | -49.1% | 0.03% | -62.8% |
| Q1 2020 | $1,202,000 | – | 54,867 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |